Obesity (determined by BMI) and blood glucose levels are by far the best predictors of whether a person will develop diabetes. Yet doctors are always on high alert for new biomarkers that may be more sensitive indicators of which patients will develop diabetes in the near future. The idea of using biomarkers to predict diabetes is not entirely new. Glycated hemoglobin (HbA1C) values are now routinely being monitored to screen for at-risk patients. However, a new study in PLoS One shows that several new biomarkers in the blood may further our understanding of exactly who’s at risk for diabetes, and increase our knowledge of the etiology of the disease.
Read More